94 related articles for article (PubMed ID: 4028949)
1. [Absence of point mutation in the 12th codon of the c-Ha-rasl transforming genes of human breast and stomach cancer, melanoma and neuroblastoma].
Kniazev PG; Schäfer R; Willecke K; Seĭts IF
Dokl Akad Nauk SSSR; 1985; 282(6):1487-9. PubMed ID: 4028949
[No Abstract] [Full Text] [Related]
2. [Identification of the transforming Ha-ras gene in human melanoma, neuroblastoma and breast cancer cells].
Kniazev PG; Schäfer R; Willecke K; Seits IF
Vopr Onkol; 1985; 31(6):77-85. PubMed ID: 4024551
[TBL] [Abstract][Full Text] [Related]
3. [Detection and molecular genetic characterization of the c-Ha-ras 1 oncogene in human breast cancer, malignant melanoma and neuroblastoma].
Kniazev PG; Schafer R; Willecke K; Seĭts IF
Dokl Akad Nauk SSSR; 1985; 283(4):1011-3. PubMed ID: 3899561
[No Abstract] [Full Text] [Related]
4. Transforming activity of the c-Ha-ras oncogene having two point mutations in codons 12 and 61.
Sekiya T; Prassolov VS; Fushimi M; Nishimura S
Jpn J Cancer Res; 1985 Sep; 76(9):851-5. PubMed ID: 3932284
[TBL] [Abstract][Full Text] [Related]
5. Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line.
Deng GR; Lu YY; Chen SM; Miao J; Lu GR; Li H; Cai H; Xu XL; E Z; Liu PN
Cancer Res; 1987 Jun; 47(12):3195-8. PubMed ID: 3034404
[TBL] [Abstract][Full Text] [Related]
6. [A molecular genetic analysis of the 12th codon of the Ha-ras-1 proto-oncogene in human carcinoma and stomach ulcer cells].
Novikov LB; Fedorov SN; Iatsuk OS; Kalinovskiĭ VP; Tlevlesov NIa; Levanova GI; Matveev BV; Mel'nikov RA; Seĭts IF
Eksp Onkol; 1990; 12(2):58-9. PubMed ID: 2180677
[TBL] [Abstract][Full Text] [Related]
7. [Detection and preliminary characteristics of the transforming gene (oncogene) of Ha-ras type in human stomach cancer].
Kniazev PG; Schäfer R; Kalinovskiĭ VP; Matveev BV; Mel'nikov RA
Mol Biol (Mosk); 1986; 20(6):1513-21. PubMed ID: 3027534
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.
Yokota J; Yamamoto T; Miyajima N; Toyoshima K; Nomura N; Sakamoto H; Yoshida T; Terada M; Sugimura T
Oncogene; 1988 Mar; 2(3):283-7. PubMed ID: 3281095
[TBL] [Abstract][Full Text] [Related]
9. [Cell oncogene expression in human stomach tumors].
Spitkovskiĭ DD; Zborovskaia IB
Vopr Onkol; 1985; 31(12):44-9. PubMed ID: 4082507
[TBL] [Abstract][Full Text] [Related]
10. Comparison studies of oncogenes in retinoblastoma and neuroblastoma.
Lee WH; Murphree AL; Benedict WF
Prog Clin Biol Res; 1985; 175():131-9. PubMed ID: 3991728
[No Abstract] [Full Text] [Related]
11. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
12. Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families.
Montagna M; Santacatterina M; Corneo B; Menin C; Serova O; Lenoir GM; Chieco-Bianchi L; D'Andrea E
Cancer Res; 1996 Dec; 56(23):5466-9. PubMed ID: 8968102
[TBL] [Abstract][Full Text] [Related]
13. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutations and BRCA1 expression in breast cancer: potential biomarkers for chemoresistance.
Santarpia M; Altavilla G; Margeli M; Cirauqui B; Mesiti M; Cavallari V; Ramirez JL; Sanchez-Ronco M; Santarpia L; Taron M; Rosell R
Cancer Invest; 2008 Dec; 26(10):1044-51. PubMed ID: 18798071
[TBL] [Abstract][Full Text] [Related]
15. [Comparative analysis of oncogene expression in normal and tumorous human tissues].
Nelkov AM
Dokl Akad Nauk SSSR; 1984; 276(5):1257-9. PubMed ID: 6206991
[No Abstract] [Full Text] [Related]
16. Differential expression of the LGI and SLIT families of genes in human cancer cells.
Rossi MR; Huntoon K; Cowell JK
Gene; 2005 Aug; 356():85-90. PubMed ID: 16000246
[TBL] [Abstract][Full Text] [Related]
17. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
18. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
[TBL] [Abstract][Full Text] [Related]
19. The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.
Pomp J; Ouwerkerk IJ; Hermans J; Wondergem J; Cornelisse CJ; Leer JW; Schrier PI
Radiat Res; 1996 Oct; 146(4):374-81. PubMed ID: 8927709
[TBL] [Abstract][Full Text] [Related]
20. Integrated profiling of basal and luminal breast cancers.
Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
